期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

需氧菌性阴道炎的发病机制及治疗进展 被引量：14

原文传递
导出
摘要 需氧菌性阴道炎（aerobic vaginitis,AV）是近年来新认识的1种阴道感染性疾病,主要由需氧菌感染引起,其特点为阴道内能产生H2O2的乳杆菌减少或缺失,其他细菌如B族链球菌、葡萄球菌、大肠埃希菌及肠球菌等需氧菌增多,并产生阴道黏膜炎性改变.由于过去对AV认识不够,将其按细菌性阴道病（bacterial vaginosis,BV）或非特异性阴道炎等进行治疗,导致治疗失败,进而引起盆腔炎症性疾病、不孕、流产、胎膜早破、早产等并发症[1-2].现对AV的发病机制及治疗现状进行综述.
作者 韩姹 范爱萍 储赞军 薛凤霞
机构地区 天津医科大学总医院妇产科
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第12期944-947,共4页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金（81471419） 天津医科大学科学基金（2013ky01）
关键词 菌性阴道炎 治疗失败 发病机制 需氧菌 阴道感染性疾病 VAGINITIS 细菌性阴道病 非特异性阴道炎
分类号 R711.31 [医药卫生—妇产科学]
  • 相关文献

参考文献28

  • 1Donati L, Di VA, Nucci M, et al. Vaginal microbial flora and outcome of pregnancy[J]. Arch Gynecol Obstet, 2010, 281: 589-600.
  • 2Tansarli GS, Kostaras EK, Athanasiou S, et al. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity [J]. Enr J Clin Microbiol Infect Dis, 2013,32:977-984.
  • 3Donders GG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis[J]. B JOG, 2002,109:34-43.
  • 4Donders GG, Vereecken A, Bosmans E, et al. Aerobic vaginitis: abnormal vaginal flora entity that is distinct from bacterial vaginosis[J]. International Congress Series, 2005.1279:118-129.
  • 5范爱萍,薛凤霞.需氧菌性阴道炎及其混合感染的临床特征分析[J].中华妇产科杂志,2010,45(12):904-908. 被引量：128
  • 6Marconi C, Donders GG, Bellen G, et al. Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis[J]. Eur J Obstet Gynecol Reprod Biol, 2013,167:205-209.
  • 7Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy[J]. B JOG,2009,116:1315-1324.
  • 8Gondo F, da Silva MG, Polettini J, et al. Vaginal flora alterations and clinical symptoms in low-risk pregnant women [J]. Gynecol Obstet Invest, 2011,71:158-162.
  • 9Zodzika J, Rezeberga D, Jermakova I, et al. Factors related to elevated vaginal pH in the first trimester of pregnancy[J]. Acta Obstet Gynecol Scand, 2011,90:41-46.
  • 10Tempera G, Abbadessa G, Bonfiglio G, et al. Topicalkanamycin: an effective therapeutic option in aerobic vaginitis [J]. J Chemother,2006,18:409-414.

二级参考文献29

  • 1BerekJS.Berek&Novak妇科学[M].第2版,郎景和,向阳译.北京:人民卫生出版社,2008:348.
  • 2Sweet RL, Gibbs RS. Infectious diseases of the female genital tract[ M ]. 4th ed, USA ,2002:351-352,612-622.
  • 3Donder GG, Vereecken A, Bosmans E, et at. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: desquamative inflammatory vaginitis [ J ]. B JOG, 2002,109 : 34 -43.
  • 4Amsel R,Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations[ J]. Am J Med, 1983,74 : 14-22.
  • 5Newbern EC, Foxman B, Leaman D, et al. Desquamative inflammatory vaginitis: an exploratory case-control study [ J]. Ann Epidemio1,2002,12:346-352.
  • 6Tempera G, Bonfiglio G, Cammarata E, et al. Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis : a pilot study [ J ]. Int J Antimicrob Agents,2004,24:85-88.
  • 7Tempera G, Abbadessa G, Bonfiglio G, et al. Topical kanamycin :an effective therapeutic option in aerobic vaginitis [ J ]. J Chemother, 2006,18:409-414.
  • 8Donders GGG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis [J]. Br J Obstet Gynaecol,2002, 109( 1 ) : 34 -43.
  • 9Tempera G, Bonfiglio G, Cammarata E, et al. Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study [ J ]. International Journal of Antimicrobial Agents,2004,24( 1 ) :85 - 88.
  • 10Tempera G, Abbadessa G, Bonfiglio G, et al. Topical kanamycin: an effective therapeutic option in Aerobic Vaginitis [ J]. Jounal of Chemothrapy,2006,18(4) :409 -414.

共引文献191

同被引文献179

  • 1李小利,王本杰,魏春敏,郭瑞臣.硝呋太尔人体药代动力学研究[J].中国药物应用与监测,2005,2(4):8-11. 被引量：4
  • 2顾美皎.泌尿生殖道衣原体和支原体感染的规范治疗[J].中国实用妇科与产科杂志,2005,21(11):645-646. 被引量：16
  • 3牟晓欣,张勇.FE复合酶治疗烧伤创面感染的疗效观察[J].实用医学杂志,2006,22(9):1059-1060. 被引量：15
  • 4Hengartner MP,Passalacqua S,Heim G,et al.The Post-Discharge network coordination programme:a randomized controlled trial to evaluate the efficacy of an intervention aimed at reducing rehospitalizatious and improving mental health[J].Front Psychiatry,2016,7(4):27.
  • 5Theill L,Dudiuk C,Morano S,et al.Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argenlina[J].Rev Argent Microbiol,2016,48(1):43-49.
  • 6Nash EE,Peters BM,Lilly EA,et al.A murine model of Candida glabrata vaginitis shows no evidence of an inflammatory immunopathogenic response[J].PLoS One,2016,11(1):e0147969.
  • 7Goncalves B,Ferreira C,Alves CT,et al.Vulvovaginal candidiasis;Epidemiology,microbiology and risk factors[J].Crit Rev Microbiol,2015,25(4):l-23.
  • 8Aznar-Marin P,Galan-Sanchez F,Marin-Casanova P,et al.Candida nivariensis as a new emergent agent of vulvovaginal candidiasis:description of cases and review of published studies[J].Mycopathologia,2016,181(5/6):445-449.
  • 9Ugwa EA.Vulvovaginal candidiasis in aminu Kano teaching hospital,North-West Nigeria:Hospital-Based epidemiological study[J].Ann Med Health Sci Res,2015,5(4):274-278.
  • 10Tempera G, Bonfiglio G, Cammarata E, et al. Microbiological/ clinical characteristics and validation of topicaltherapy with ka- namycin in aerobic vaginitis: a pilot study. International Journal of Antimicrobial Agents, 2004, 24: 85-88.

引证文献14

二级引证文献176

中华妇产科杂志
2014年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部